🔗 Visit the ClinicalTrials.gov page for NCT01208831
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. | Nat Rev Clin Oncol | 2015 | 2.02 |
| 2 | The rationale for targeted therapies in medulloblastoma. | Neuro Oncol | 2013 | 0.92 |
| 3 | Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. | Cancer Growth Metastasis | 2015 | 0.90 |
| 4 | Targeted treatment for sonic hedgehog-dependent medulloblastoma. | Neuro Oncol | 2014 | 0.83 |
| 5 | MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor. | FASEB J | 2015 | 0.80 |
| 6 | Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors. | Cancer Sci | 2016 | 0.80 |
| 7 | Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma. | J Exp Pharmacol | 2012 | 0.75 |